Age-correlated loss of dopamine uptake sites labeled with [³H]GBR-12935 in human putamenALLARD, P; MARCUSSON, J. O.Neurobiology of aging. 1989, Vol 10, Num 6, pp 661-664, issn 0197-4580Article

Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer typeALLARD, P. O; RINNE, J; MARCUSSON, J. O et al.Brain research. 1994, Vol 637, Num 1-2, pp 262-266, issn 0006-8993Article

Drug inhibition indicates a single-site model of the 5-HT uptake site/antidepressant binding site in rat and human brainMARCUSSON, J. O; ANDERSSON, A; BACKSTROM, I et al.Psychopharmacologia. 1989, Vol 99, Num 1, pp 17-21, issn 0033-3158Article

High-and low-affinity [³H]desipramine-binding sites in human postmortem brain tissueBÄCKSTRÖM, I. T; MARCUSSON, J. O.Neuropsychobiology. 1990, Vol 23, Num 2, pp 68-73, issn 0302-282XArticle

[³H]WIN 35,428 binding in the human brainALLARD, P; MARCUSSON, J. O; ROSS, S. B et al.Brain research. 1996, Vol 706, Num 2, pp 347-350, issn 0006-8993Article

[³H]GBR-12935 binding to cytochrome P450 in the human brainALLARD, P; MARCUSSON, J. O; ROSS, S. B et al.Journal of neurochemistry. 1994, Vol 62, Num 1, pp 342-348, issn 0022-3042Article

Characterization of [³H]paroxetine binding in rat brainMARCUSSON, J. O; BERGSTROM, M; ERIKSSON, K et al.Journal of neurochemistry. 1988, Vol 50, Num 6, pp 1783-1790, issn 0022-3042Article

Unaltered [³H]GBR-12935 binding after chronic treatment with dopamine active drugsALLARD, P; ERIKSSON, K; ROSS, S. B et al.Psychopharmacology. 1990, Vol 102, Num 3, pp 291-294, issn 0142-8411, 4 p.Article

[³H]Desipramine binding to rat brain tissue: binding to both noradrenaline uptake sites and sites not related to noradrenaline neuronsBACKSTROM, I. T; ROSS, S. B; MARCUSSON, J. O et al.Journal of neurochemistry. 1989, Vol 52, Num 4, pp 1099-1106, issn 0022-3042, 8 p.Article

Adrenergic, serotoninergic, histaminergic and imipramine binding sites in post-mortal human cerebral microvessel preparationsOï'NEILL, C; FOWLER, C. J; MARCUSSON, J. O et al.Journal of neural transmission. 1988, Vol 73, Num 3, pp 177-189, issn 0300-9564Article

Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding siteMARCUSSON, J. O; BACKSTROM, I. T; ROSS, S. B et al.Molecular pharmacology. 1986, Vol 30, Num 2, pp 121-128, issn 0026-895XArticle

Elevated density of [³H]imipramine binding in aged human brainSEVERSON, J. A; MARCUSSON, J. O; OSTERBURG, H. H et al.Journal of neurochemistry. 1985, Vol 45, Num 5, pp 1382-1389, issn 0022-3042Article

Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with ageMARCUSSON, J. O; MORGAN, D. G; WINBLAD, B et al.Brain research. 1984, Vol 311, Num 1, pp 51-56, issn 0006-8993Article

Loss of dopamine uptake sites labeled with [³H]GBR-12935 in Alzheimer's diseaseALLARD, P; ALAFUZOFF, I; CARLSSSON, A et al.European neurology. 1990, Vol 30, Num 4, pp 181-185, issn 0014-3022Article

Divergent changes in D-1 and D-2 dopamine binding sites in human brain during agingMORGAN, D. G; MARCUSSON, J. O; NYBERG, P et al.Neurobiology of aging. 1987, Vol 8, Num 3, pp 195-201, issn 0197-4580Article

5-Hydroxytryptamine-sensitive [³H]imipramine binding of protein nature in the human brain. II: Effect of normal aging and dementia disordersMARCUSSON, J. O; ALAFUZOFF, I; BACKSTROM, I. T et al.Brain research. 1987, Vol 425, Num 1, pp 137-145, issn 0006-8993Article